These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 12066578)
1. Modifying the release of gentamicin from microparticles using a PLGA blend. Friess W; Schlapp M Pharm Dev Technol; 2002 May; 7(2):235-48. PubMed ID: 12066578 [TBL] [Abstract][Full Text] [Related]
4. Effect of polymer blending on the release of ganciclovir from PLGA microspheres. Duvvuri S; Gaurav Janoria K; Mitra AK Pharm Res; 2006 Jan; 23(1):215-23. PubMed ID: 16320000 [TBL] [Abstract][Full Text] [Related]
5. Controlled delivery of ganciclovir to the retina with drug-loaded Poly(d,L-lactide-co-glycolide) (PLGA) microspheres dispersed in PLGA-PEG-PLGA Gel: a novel intravitreal delivery system for the treatment of cytomegalovirus retinitis. Duvvuri S; Janoria KG; Pal D; Mitra AK J Ocul Pharmacol Ther; 2007 Jun; 23(3):264-74. PubMed ID: 17593010 [TBL] [Abstract][Full Text] [Related]
6. Development of a novel formulation containing poly(d,l-lactide-co-glycolide) microspheres dispersed in PLGA-PEG-PLGA gel for sustained delivery of ganciclovir. Duvvuri S; Janoria KG; Mitra AK J Control Release; 2005 Nov; 108(2-3):282-93. PubMed ID: 16229919 [TBL] [Abstract][Full Text] [Related]
7. Gentamicin encapsulation in PLA/PLGA microspheres in view of treating Brucella infections. Prior S; Gamazo C; Irache JM; Merkle HP; Gander B Int J Pharm; 2000 Feb; 196(1):115-25. PubMed ID: 10675713 [TBL] [Abstract][Full Text] [Related]
8. In vitro phagocytosis and monocyte-macrophage activation with poly(lactide) and poly(lactide-co-glycolide) microspheres. Prior S; Gander B; Blarer N; Merkle HP; Subirá ML; Irache JM; Gamazo C Eur J Pharm Sci; 2002 Mar; 15(2):197-207. PubMed ID: 11849917 [TBL] [Abstract][Full Text] [Related]
9. Influence of the microencapsulation method and peptide loading on poly(lactic acid) and poly(lactic-co-glycolic acid) degradation during in vitro testing. Witschi C; Doelker E J Control Release; 1998 Feb; 51(2-3):327-41. PubMed ID: 9685930 [TBL] [Abstract][Full Text] [Related]
11. Influence of PLGA End Groups on the Release Profile of Dexamethasone from Ocular Implants. Saraf I; Kushwah V; Alva C; Koutsamanis I; Rattenberger J; Schroettner H; Mayrhofer C; Modhave D; Braun M; Werner B; Zangger K; Paudel A Mol Pharm; 2023 Feb; 20(2):1307-1322. PubMed ID: 36680524 [TBL] [Abstract][Full Text] [Related]
12. Polymer and microsphere blending to alter the release of a peptide from PLGA microspheres. Ravivarapu HB; Burton K; DeLuca PP Eur J Pharm Biopharm; 2000 Sep; 50(2):263-70. PubMed ID: 10962237 [TBL] [Abstract][Full Text] [Related]
13. Hydrophilic poly(DL-lactide-co-glycolide) microspheres for the delivery of DNA to human-derived macrophages and dendritic cells. Walter E; Dreher D; Kok M; Thiele L; Kiama SG; Gehr P; Merkle HP J Control Release; 2001 Sep; 76(1-2):149-68. PubMed ID: 11532321 [TBL] [Abstract][Full Text] [Related]
14. A synthetic polymer matrix for the delayed or pulsatile release of water-soluble peptides. Schachter DM; Kohn J J Control Release; 2002 Jan; 78(1-3):143-53. PubMed ID: 11772456 [TBL] [Abstract][Full Text] [Related]